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Over the last 20 years researchers have explored the postulated role of acetaldehyde
(ACD) as a mediator of some of the actions of ethanol (EtOH) in the central nervous
system (CNS). However, efforts have been hampered mainly by the difficulty of directly
measuring in vivo EtOH and ACD levels in the CNS and thus, our knowledge is based
on indirect evidences. Although technically challenging, the development of reliable
methods for in vivo measurement of ACD and EtOH is of paramount importance
to solve the “puzzle of acetaldehyde as a neuroactive agent.” In this short review
we discuss the recent advances on brain EtOH pharmacokinetic and state-of-the-
art available techniques that could be used for in vivo detect EtOH and ACD both
non-invasively (magnetic resonance spectroscopy), and invasively (microdialysis and
biosensors). Among the different in vivo sampling techniques described, particular
emphasis is paid to the field of enzyme-based amperometric biosensors. Biosensors
have gained much attention in recent years for their ability to online monitor biological
signals in vivo, and several micro- and nano-structured devices have been successfully
used for in vivo studies. Owing to their high temporal and spatial resolution, biosensors
could provide the adequate technology for studying in vivo EtOH pharmacokinetic.
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INTRODUCTION
Acetaldehyde (ACD) is a naturally occurring compound, found in several fruits and vegetables as
well as in tobacco smoke and fermented alcoholic beverages (Cao et al., 2007).
In the last decades many attempts have been made to quantify brain EtOH and ACD, in order
to correlate their concentrations with behavior (Correa et al., 2012; Israel et al., 2015). So far this
line of research has yielded conflicting results, mostly due to discrepancy and controversy with
quantitative measures of brain EtOH and ACD.
In this brief review we offer an overview of the recent advances on brain EtOH pharmacokinetic
and discuss the state-of-the-art of available techniques for in vivo EtOH and ACD study.
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EtOH METABOLISM IN THE BRAIN
Since EtOH readily enters the brain, in situ synthesis has been
long postulated as a plausible source of brain ACD (Cohen
et al., 1980). It is now demonstrated that the brain tissue
contains all of the main EtOH metabolizing enzymes: alcohol
dehydrogenase (ADH), cytochrome P450 2E1 (CYP2E1), and
catalase; however, their relative role in metabolizing EtOH into
ACD is still debated.
Alcohol dehydrogenase is a zinc-containing enzyme localized
in the cytosol, it has broad substrate specificity (many primary
or secondary alcohols) and is found in highest amount in the
liver. However, since ADH is not uniformly expressed in the brain
tissue, its real contribution to local ACD levels in discrete brain
areas could have been underestimated and may deserve more
detailed evaluation (Bühler et al., 1983; Kerr et al., 1989; Mori
et al., 2000).
Cytochrome P450s are a family of heme enzymes mainly
located in the endoplasmic reticulum and in mitochondria.
CYP2E1 is the P450 family with the highest activity for oxidizing
EtOH to ACD, and is widely expressed in the human and
rodent brain (Tindberg and Ingelman-Sundberg, 1996; Sánchez-
Catalán et al., 2008; Ferguson and Tyndale, 2011). CYP2E1
has been shown to metabolize EtOH in both neurons and
astrocytes at a rate of 0.00051 µmol/min/g, and CYP2E1
pharmacological inhibition significantly reduces ACD formation
in rat brain homogenates incubated with EtOH (Hansson
et al., 1990; Gill et al., 1992; Warner and Gustafsson, 1994;
Zimatkin et al., 2006). Further, reduced ACD brain levels have
been shown in transgenic KO CYP2E1 mice after incubation
with EtOH, relative to their wild-type counterparts (Ziegler
et al., 2006). CYP2E1 activity has been accounted for a 20%
fraction of brain EtOH oxidation, and it may represents a
major adaptive response to chronic EtOH consumption as
shown in a recent in vivo study on EtOH-induced locomotion
(Hansson et al., 1990; Heit et al., 2013; Ledesma et al.,
2014). Further, in vitro evidences in KO CYP2E1, acatalasemic
and double mutants (KO CYP2E1 and acatalasemic) mice,
suggest that CYP2E1 function may be linked to catalase-
mediated EtOH oxidation by increasing the availability of
H2O2 (Halliwell, 2006; Zimatkin et al., 2006; Deng and Ra,
2008).
Catalase, a heme containing enzyme, is found in the
peroxisomal fraction of the cell and can oxidize EtOH as shown
in reaction 1.
(1) CH3CH2OH + H2O2 → CH3CHO + 2H2O
Recent results also show that 3-amino-1,2,4-triazole (3AT)
administration impair the acquisition of operant EtOH self-
administration in the rat (Peana et al., 2015). However, 3AT
has been shown to cause a non-specific effects on behavior and
therefore other procedures have been used to inhibit catalase-
mediated ACD formation (Rotzinger et al., 1994; Tampier et al.,
1995).
A valuable method for in vivo studying the involvement of
catalase in brain ACD formation is based on the use of lentiviral
vectors coding for an anticatalase shRNA (RNAi precursor),
which allows for efficient (up to 75%) inhibition of catalase
activity (Karahanian et al., 2011). This technique appears also
of particular interest because by allowing localized inhibition of
catalase activity, it may be used to precisely pinpoint those brain
areas involved in the psychopharmacological effects of EtOH
(Israel et al., 2015). In fact, it has been shown that administration
of an anticalatase vector into the ventral tegmental area (area
which plays a key role in the neurobiological basis of addiction,
VTA), significantly reduced EtOH consumption and EtOH
stimulated dopamine release in its projection fields (in particular
the nucleus accumbens shell) (Karahanian et al., 2011; Israel
et al., 2012; Quintanilla et al., 2012). Another study show that
anticatalase vectors administration in the VTA can efficiently
inhibit EtOH intake following deprivation (Tampier et al.,
2013).
IN VIVO EtOH AND ACD DETECTION:
NON-INVASIVE APPROACHES
Magnetic Resonance Spectroscopy
Magnetic resonance spectroscopy (MRS) is a non-invasive
analytical technique used to provide a measure of in vivo
brain biochemistry (Soares and Law, 2009; Strózik-Kotlorz,
2014; Buonocore and Maddock, 2015). In vivo MRS can be
performed with common clinical magnetic resonance imaging
equipments and since EtOH methyl protons can be detected
(Sammi et al., 2000), MRS has been largely used to measure
in vivo brain EtOH levels in both humans and laboratory
animals (Hanstock et al., 1990; Kaufman et al., 1994; Rooney
et al., 2000; Zahr et al., 2010). However, magnetic transfer
evidences have clearly shown the in vivo presence of a free,
observable EtOH pool and a membrane-associated EtOH pool
that escapes direct detection (Fein and Meyerhoff, 2000; Nagel
and Kroenke, 2008). Therefore, since a (possibly significant)
fraction of brain EtOH content cannot be measured by
MRS, this technique must be considered only for qualitative
measurements.
Ethanol oxidative metabolism has been studied with MRS,
after 13C-labeled EtOH administration (Xiang and Shen, 2011;
Wang et al., 2013a,b).The results show that 13C nuclei from
13C-labeled EtOH are incorporated into multiple metabolites
including glutamate, glutamine, and aspartate, but no significant
conversion of EtOH into ACD in the brain could be
evidenced.
Despite the low sensitivity and temporal resolution, MRS
still provides an opportunity for in vivo qualitative study of
the effects of EtOH in the brain (Nagel and Kroenke, 2008;
Niciu and Mason, 2014). MRS is fundamental for human
studies allowing the dynamic evaluation of EtOH effects, and
providing an important framework for comparing experimental
results in humans and animal models (Cifuentes Castro et al.,
2014). Further, since magnetic resonance images can be obtained
concurrently with spectroscopic data, MRS also provides valuable
structural informations (Alger, 2010; Befroy and Shulman,
2011).
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IN VIVO EtOH AND ACD DETECTION:
INVASIVE APPROACHES
Microdialysis
Microdialysis is de facto the gold-standard in vivo sampling
technique for the central nervous system (CNS), allowing the
analysis of several molecules in cerebro spinal fluid (CSF)
based on their diffusion across a semi-permeable membrane
(Chefer et al., 2009; Kennedy, 2013). Despite its popularity,
microdialysis is not free of limitations (Westerink, 1995), some
of which are particularly relevant for EtOH and ACD in vivo
measurement. In particular, due to low probe recovery, the
concentrations of substances in the dialysate only partially
reflect true tissue concentrations and thus, analytes present
at very low concentrations are difficult to detect. This issue
could be also worsened by the fact that some compounds
may be adsorbed by the dialysis membrane further decreasing
probe recovery (Buttler et al., 1996). It is well-known that
microdialysis has poor time resolution and therefore is not
suitable for studying events that change in short time intervals.
Another problem is the effect of tissue damage secondary
to probe implantation; although microdialysis probes have
been miniaturized in time, alterations in tissue metabolism
cannot be neglected (Borland et al., 2005; Carson et al.,
2015).
Despite all technical shortcomings, the advantages of using
microdialysis for in vivo monitoring of brain neurochemistry
are clear. Microdialysis is a well-known and widely reproduced
technique, sampling can be performed on freely moving subjects,
and long-term studies can be carried out with minimal influence
on the brain tissue physiology (Westerink, 1995; Chefer et al.,
2009; Kennedy, 2013). On these bases, several authors used
brain microdialysis to study EtOH and ACD in vivo (Yoshimoto
and Komura, 1993; Jamal et al., 2003, 2007, 2015). However,
this approach yielded only limited results, mostly due to the
various technical and analytical issues which specifically impair
the usefulness of microdialysis for EtOH and (especially) ACD
in vivo monitoring.
High Performance Liquid Chromatography (HPLC)
High performance liquid chromatography (HPLC)-based
analytical methods are largely employed in microdialysis studies
(Cheng et al., 2009; Guihen and O’Connor, 2009). With regard
to EtOH and ACD determination HPLC-based methods appear
particularly suitable, since samples are not heated during analysis
and thus heat sensitive or volatile compounds (such as EtOH
and ACD) can be efficiently separated. Several protocols for
EtOH analysis with HPLC have been developed using flame
ionization detection (Yarita et al., 2002), ultraviolet detection
after conversion to acetaldehyde-phenylhydrazone (Pellegrino
et al., 1999), indirect photometric detection (Takeuchi et al.,
1988), and enzymatic assay (Kristoffersen and Smith-Kielland,
2005; Peris et al., 2006). An optimized HPLC-based protocol for
ACD determination in biological samples after derivatization
with dinitrophenylhydrazine (Vogel et al., 2000) and diode array
detector is also available (Guan et al., 2011).
Gas Chromatography (GC)
Gas chromatography (GC) is an efficient analytical technique for
separating volatile species in complex samples, and several GC-
based protocols have been developed for the detection of EtOH
and ACD in biological matrices.
Several detector types can be used in conjunction with GC for
EtOH and ACD detection; the most efficient protocols available
have been developed mainly using mass spectrometry (GC–MS)
(Heit et al., 2016) or flame ionization (GC-FID) (Chun et al.,
2016), alone or in combination (Tiscione et al., 2011).
Gas chromatography with headspace extraction and mass
spectrometry or flame ionization detection is the most reliable
and sensitive technique available for EtOH and ACD detection
in microdialysates (Xiao et al., 2014; Heit et al., 2016). Indeed,
owing to their robustness and reliability, GC-based EtOH analysis
are the gold standard technique for blood alcohol concentration
measurement in forensic and toxicological laboratories (Cordell
et al., 2013; Xiao et al., 2014; Goullé and Guerbet, 2015).
Fluorimetry
A new fluorimetry-based analytical method for EtOH and ACD
has been recently published (Zachut et al., 2016). Although
not specifically developed for EtOH and ACD detection in
brain dialysates, this technique appears quite compatible with
microdialysis; in particular: small sample volume, no sample
pre-processing, simple methodology, relatively inexpensive
laboratory equipment. Further, the limits of detection of the
technique are reported to be comparable with the performance
of GC methods.
Biosensors
A biosensor can be defined as “a self-contained analytical device
that combines a biological component with a physicochemical
device for the detection of an analyte of biological importance”
(Hasan et al., 2014). Biosensors typically consist of two key
components: (1) a biological recognition element to detect the
analyte; (2) a transducer to convert the biological response into
a convenient output signal.
Among the different devices available, amperometric enzyme-
based biosensors (AEBs) are increasingly employed in in vivo
brain monitoring (Thévenot et al., 2001; Weltin et al., 2016). In
fact, miniature (active surface – 1 mm, diameter – 150 µm) AEBs
implantation induces reduced tissue damage, allows for real-
time monitoring, with high sensitivity and specificity for analytes
which cannot be studied with microdialysis (Timmerman and
Westerink, 1997; Sirca et al., 2014). Another important feature of
biosensors is the possibility of associating the implanted device
to a telemetric system, allowing experiments in freely moving
subjects (Olivo et al., 2011).
Amperometric enzyme-based biosensors are mainly based on
enzymes that belong to two classes: oxidases and dehydrogenases;
in their most common implementation the enzyme is linked
on the transducer surface and the output signal is generated by
measuring the electroactive by-products of enzymatic reaction.
In recent years several AEBs for EtOH detection have
been developed, based on both alcohol oxidase (AOx) or
dehydrogenase (ADH).
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Alcohol oxidase catalyzes the oxidation of aliphatic, low
molecular weight alcohols to their respective aldehydes using
molecular oxygen (O2) as the electron acceptor and flavin-
adenine dinucleotide (FAD) as cofactor (reactions 2 and 3).
(2) R-CH2OH + AOx/FAD → R-CHO + AOx/FADH2
(3) AOx/FADH2 + O2 → AOx/FAD + H2O2
(4) H2O2 → O2 + 2H+ + 2e−
The hydrogen peroxide produced by reaction 3 can be
directly detected at the transducer surface of AOx-based AEBs
(reaction 4). However, the high anodic potential needed to
oxidize H2O2 poses a problem of Faradaic interference due to
the presence of other compounds (such as ascorbic acid and
uric acid) physiologically present in high concentrations in the
CSF, which are also oxidized at the same potential (Belluzo
et al., 2008). The use of a bi-enzyme AEB is a common way
to circumvent this problem. In fact, by coupling a peroxidase
[usually horseradish peroxidase (HRP)] to AOx it is possible to
indirectly monitor EtOH-derived H2O2 at low working potentials
reducing interfering signals (Vijayakumar et al., 1996; Azevedo
et al., 2005).
(5) H2O2 + 2H+ + HRP− → 2H2O + HRP+
The HRP+/HRP− redox couple (reaction 5) is used as the sensing
scheme at the transducer surface of AOx/HRP-based AEBs.
Alcohol dehydrogenase catalyzes the reversible oxidation of
primary aliphatic and aromatic alcohols using nicotinamide-
adenine dinucleotide (NAD) as cofactor (reaction 6).
(6) R-CH2OH + ADH/NAD+ → R-CHO + ADH/NADH + H+
(7) NADH → NAD+ + H+ + 2e−
The most common way to monitor an ADH-catalyzed
reaction is by using the NAD+/NADH redox couple (reaction 7)
as the sensing scheme at the transducer surface of ADH-based
AEBs (Lorenzo et al., 1998).
Acetaldehyde biosensors developed so far are based on
ALDH, which catalyzes the oxidation of biogenic and xenobiotic
aldehydes (including ACD) into acetate using NAD as cofactor
(reaction 8).
(8) R-CHO + ALDH/NAD+ → R-COOH + ALDH/NADH + H+
(9) NADH → NAD + H+ + 2e−
The ALDH-catalyzed reaction is monitored by using the
NAD+/NADH redox couple (reaction 9) as the sensing scheme
at the transducer surface of ALDH-based AEBs (Lorenzo et al.,
1998).
Acetaldehyde biosensors have been mostly developed for
toxicological and industrial purposes and therefore their
biological applicative potential is much less characterized, when
compared with EtOH AEBs. However the available evidence
show that these devices can efficiently detect ACD in the µM
range in vitro, with high time resolution and substrate specificity
(Noguer and Marty, 1997; Noguer et al., 2001; Avramescu et al.,
2002; Yao and Handa, 2003; Ghica et al., 2007).
Although the development of an adequate biosensor
technology for in vivo EtOH and ACD detection is still in its
infancy, the available evidence clearly show that this approach
holds tremendous technological potential. In fact the prototypical
properties of biosensors including high spatial and temporal
resolution together with high sensitivity and specificity, render
these devices the best candidates for in vivo accurate EtOH and
ACD detection.
Several AEBs for in vivo EtOH determination are already
commercially available; however since in vivo biosensors use is
not deprived of drawbacks, the fundamentals of this technology
are to be well-understood in order to obtain reproducible
results (Vigneshvar et al., 2015; Weltin et al., 2016). In
particular, the interactions of the implanted AEB with the
biological environment may severely affect its bioanalytical
performances via metabolic biofouling, electrode passivation,
or biodegradation. Metabolic biofouling is probably the most
important problem being able to quickly alter sensitivity, limit
of detection, and linear response of the implanted device
(Gifford et al., 2006; Kotanen et al., 2012). Unfortunately,
biocompatibility-based issues cannot be easily circumvented and
adequate pre- and post-calibration procedures are needed in
order to properly evaluate in vivo AEBs measurements (Wilson
and Gifford, 2004; Wahono et al., 2012). However it is expected
that the forthcoming generation of biosensors, either based on
nanoscale or polymeric materials, will greatly help reducing
biocompatibility issues (Nichols et al., 2013; Weltin et al., 2014;
Saxena and Das, 2016).
CONCLUSION
The many attempts to quantify ACD in the brain have yielded
conflicting results, mainly because of the inadequacy of the
available analytical techniques. Thus, it is clear that in order
to solve the puzzle of ACD as a neuroactive agent we need to
use adequate analytical tools, fostering their improvement, while
discarding the most problematic approaches.
Spectroscopic techniques have proved to be useful for
studying in vivo brain EtOH kinetics, in both humans and
experimental animals, but ACD measurement remains outside
MRS analytical scope. Nevertheless, owing to its absolute
non-invasive nature MRS provides a great opportunity for
in vivo qualitative study of the effects of EtOH in the intact
brain.
Brain microdialysis is a well-known sampling technique for
in vivo applications. However, it is now clear that many of
the features that made microdialysis so successful for in vivo
monitoring of several neurochemicals, are of limited use when
coming to in vivo EtOH and (especially) ACD analysis. Its
invasiveness together with the low temporal resolution, and the
necessity of complex analytical procedures, represent the most
important problems.
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Biosensors are the emerging tool for the preclinical in vivo
study of neurochemistry. When compared to microdialysis the
main advantages of AEBs are represented by their reduced
invasiveness, high time resolution, and the possibility to detect
analytes which cannot be studied with microdialysis. In the
case of EtOH monitoring, AOX-based AEBs have proved to
be capable of in vitro and in vivo detecting concentrations
of EtOH in the µM range. ALDH-based ACD AEBs have
not been applied for in vivo ACD detection yet, however
in vitro data strongly suggest that these devices may represent
the most promising opportunity for in vivo brain ACD
detection.
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